While vaccination studies against coronavirus, which has affected the whole world, started in many countries, news came from England that would create a different effect in the fight against the epidemic. It was stated that the drug, developed by the British pharmaceutical company GlaxoSmithKline (GSK), reduced hospital admissions and mortality rates by 85 percent.
DISCONTINUED IN HEAVY CASE
British pharmaceutical company GSK announced that a new drug reduced hospital admissions and mortality rates by 85 percent in patients most at risk in coronavirus.
According to the statement made by the company, the drug called VIR-7831 was developed jointly with California-based Vir Biotechnology.
In the tests involving 583 patients who were considered to be at high risk of hospitalization in case of Kovid-19 contamination, the drug based on monoclonal antibody treatment was seen to reduce hospitalization or deaths by up to 85 percent in mild and moderate cases, but its use in severe cases was stopped because it did not provide any benefit. / p>
CLEANSE INFECTED CELLS
It has been determined that the drug both prevents the virus from entering healthy cells and helps it cleanse the already infected cells in the immune system. The company stated that it will ask for an emergency use permit in the USA, and that an application can be made in the UK.
Betbaba136.com giriş sonrası hızlı bahis oynayabilir ve hemen kazanç sahibi olacak işlemlerde bulunabilirsiniz. Betbaba136.com casino oynama sitesinde yer alan masa oyunlarından da 3D ve sanal şekilde kazanç sağlayabilirsiniz. Betbaba136.com canlı casino oyun seçenekleri yüklemesiz sunuluyor. saniyesinde açılan oyunlarda hemen kazanç sağlayabilirsiniz.